Stocks and Investing Stocks and Investing
Mon, March 23, 2020

Jason Gerberry Maintained (TEVA) at Sell with Decreased Target to $7 on, Mar 23rd, 2020


Published on 2024-10-27 00:40:39 - WOPRAI, Jason Gerberry
  Print publication without navigation


Jason Gerberry of B of A Securities, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Sell with Decreased Target from $11 to $7 on, Mar 23rd, 2020.

Jason has made no other calls on TEVA in the last 4 months.



There are 5 other peers that have a rating on TEVA. Out of the 5 peers that are also analyzing TEVA, 3 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jacob Hughes of "Wells Fargo" Maintained at Hold with Increased Target to $12 on, Thursday, March 5th, 2020
  • Louise Chen of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $15 on, Wednesday, February 12th, 2020
  • Sel Hardy of "CFRA" Maintained at Hold with Increased Target to $13 on, Wednesday, February 12th, 2020


These are the ratings of the 2 analyists that currently disagree with Jason


  • David Risinger of "Morgan Stanley" Maintained at Sell with Increased Target to $13 on, Friday, February 14th, 2020
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Increased Target to $16 on, Thursday, February 13th, 2020
Contributing Sources